26 results
Thumbnail

D2.283 - Beyond the skin. A rare case of contact angioedema due to Methylisothiazolinone

Thumbnail

D2.292 - Epinephrine Nasal Powder - a sustainable and reliable option for the treatment of anaphylaxis

Thumbnail

D2.293 - Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients

Thumbnail

D2.278 - National Survey on Perioperative Hypersensitivity Reactions: Evaluating Practices and Challenges in Spanish Hospitals

Thumbnail

D2.279 - In an emergency, can YOU really give that adrenaline pen? – the need for structured, further and improved training in Ireland

Thumbnail

D2.282 - IgE-mediated anaphylaxis to quinine confirmed with a basophil activation test

Thumbnail

D2.284 - Eat the fruit, do not swallow the seed: A rare case of Cucurbitaceae allergy causing anaphylaxis

Thumbnail

D2.286 - A case of prawn induced FDEIA

Thumbnail

D2.287 - Evaluation of NSAID Hypersensitivity in Children: A Retrospective Analysis

Thumbnail

D2.288 - Idursulfase Hypersensitivity Reactions: Unpacking Immunological Mechanisms Beyond Clinical Manifestations

Thumbnail

D2.289 - A Cardiovascular Enigma in the Emergency Room

Thumbnail

D2.290 - Allergens involved in a case report of anaphylaxis to ginger (Zingiber officinale), a very rare but severe allergy

Thumbnail

D2.291 - The level of knowledge of adolescent and young adults about food allergies and anaphylaxis: Key information that can save lives - a pilot study

Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.102 - PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

- D3.104 - A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

Thumbnail

- D3.105 - Suspected EGPA in a patient on Dupilumab treatment: confirmed diagnosis of sarcoidosis - case report

Thumbnail

- D3.106 - Real-World Dupilumab Effectiveness Through 18 Months in Patients with CRSwNP and Coexisting Asthma: Results from the Global AROMA Registry

Thumbnail

- D3.108 - PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma